The $4.5 billion investment will create the Lilly Medicine Foundry, a center that will combine research and manufacturing ...

PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

U.S. drugmaker Eli Lilly said on Wednesday it will invest $4.5 billion to create a new center for advanced manufacturing and ...

The initiative is expected to optimise processes, boost trial medicine capacity, and reduce both costs and environmental ...

Eli Lilly announced Wednesday it will invest another $4.5 billion into a new facility at the states controversial LEAP ...

Eli Lilly’s juggernaut diabetes and obesity drugs Mounjaro and Zepbound have been erased from the FDA’s shortage list, ...

The new funding will bring the Indianapolis-based drugmaker’s total investment in the Lebanon site to more than $13 billion, ...

Officials said this would help allow the pharmaceutical company to support current and future pipeline of medicines.

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Eli Lilly & Co (LLY – Research ...

Eli Lilly and Co. (Indianapolis, Ind.) announced a $4.5-billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing ...

The center, Lilly Medicine Foundry, will focus on researching new ways of producing medicines and scale up manufacturing for ...

Deutsche Bank analyst James Shin maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price target of ...